{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:11:43Z","timestamp":1778069503403,"version":"3.51.4"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aortic stenosis (AS) is the most common valvular heart disease in Western countries. Current clinical guidelines recommend intervention exclusively for severe AS, given its association with poor short-term prognosis. However, accumulating evidence over recent years suggests that even moderate AS may be associated with adverse outcomes, particularly in patients with heart failure with reduced ejection fraction (HFrEF). Consequently, an early aortic valve replacement (AVR) strategy could potentially improve survival and reduce heart-failure\u2013related hospitalizations. Moreover, treating moderate AS in patients with HFrEF may reduce left ventricular afterload and improve haemodynamic status, thereby facilitating the initiation and\/or up-titration of guideline-directed medical therapy (GDMT), especially when such therapy is poorly tolerated due to hypotension or other hypoperfusion-related factors. Nevertheless, the available evidence is derived predominantly from retrospective observational studies. The only published randomized controlled trial to date (the TAVR UNLOAD trial) failed to demonstrate a prognostic benefit of transcatheter aortic valve implantation (TAVI) in patients with moderate AS and HFrEF or heart failure with mildly reduced ejection fraction (HFmrEF). Two additional ongoing randomized trials may ultimately provide more definitive evidence. In summary, although the pathophysiological rationale is sound and the available data are encouraging, an early AVR strategy in moderate AS cannot currently be regarded as evidence-based.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suag016","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:43:24Z","timestamp":1773146604000},"page":"v1-v4","source":"Crossref","is-referenced-by-count":0,"title":["Heart Failure and Moderate Aortic Stenosis: is Early TAVI the Better Strategy?"],"prefix":"10.1093","volume":"28","author":[{"given":"Michele","family":"Legati","sequence":"first","affiliation":[{"name":"Institute of Cardiology, ASST Spedali Civili and University of Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health , Piazzale Spedali Civili 1, 25100 Brescia ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Branca","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, ASST Spedali Civili and University of Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health , Piazzale Spedali Civili 1, 25100 Brescia ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Cersosimo","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, ASST Spedali Civili and University of Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health , Piazzale Spedali Civili 1, 25100 Brescia ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Adamo","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, ASST Spedali Civili and University of Brescia, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health , Piazzale Spedali Civili 1, 25100 Brescia ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2026050607120240300_suag016-B1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/CIRCULATIONAHA.119.041080","article-title":"Contemporary presentation and management of valvular heart disease: the EURObservational research programme valvular heart disease II survey","volume":"140","author":"Iung","year":"2019","journal-title":"Circulation"},{"key":"2026050607120240300_suag016-B2","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1002\/ejhf.70023","article-title":"Management of aortic stenosis and chronic heart failure: a clinical consensus statement of the heart failure association (HFA) and the European association of percutaneous cardiovascular interventions (EAPCI) of the ESC","volume":"27","author":"Adamo","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026050607120240300_suag016-B3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ejhf.2908","article-title":"Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: an analysis of the ESC heart failure long-term registry","volume":"25","author":"Shahim","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026050607120240300_suag016-B4","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"2026050607120240300_suag016-B5","doi-asserted-by":"crossref","first-page":"e033872","DOI":"10.1161\/JAHA.123.033872","article-title":"Moderate aortic valve stenosis is associated with increased mortality rate and lifetime loss: systematic review and meta-analysis of reconstructed time-to-event data of 409 680 patients","volume":"13","author":"Jacquemyn","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026050607120240300_suag016-B6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2023.01.032","article-title":"Impact of moderate aortic stenosis in patients with heart failure with reduced ejection fraction","volume":"81","author":"Khan","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026050607120240300_suag016-B7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jcmg.2022.10.009","article-title":"Aortic stenosis progression: a systematic review and meta-analysis","volume":"16","author":"Willner","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026050607120240300_suag016-B8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcmg.2018.10.021","article-title":"Moderate aortic stenosis and heart failure with reduced ejection fraction: can imaging guide us to therapy?","volume":"12","author":"Pibarot","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026050607120240300_suag016-B9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.echo.2021.02.014","article-title":"Natural history of moderate aortic stenosis with preserved and low ejection fraction","volume":"34","author":"Mann","year":"2021","journal-title":"J Am Soc Echocardiogr"},{"key":"2026050607120240300_suag016-B10","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jcmg.2021.04.009","article-title":"Prognostic implications of associated cardiac abnormalities detected on echocardiography in patients with moderate aortic stenosis","volume":"14","author":"Amanullah","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026050607120240300_suag016-B11","doi-asserted-by":"crossref","first-page":"102348","DOI":"10.1016\/j.jacadv.2025.102348","article-title":"Cardiac damage staging, moderate aortic stenosis, and the impact of aortic valve replacement","volume":"4","author":"Harmon","year":"2025","journal-title":"JACC Adv"},{"key":"2026050607120240300_suag016-B12","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/heartjnl-2022-320886","article-title":"Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis","volume":"108","author":"Stassen","year":"2022","journal-title":"Heart"},{"key":"2026050607120240300_suag016-B13","doi-asserted-by":"crossref","first-page":"e012768","DOI":"10.1161\/CIRCINTERVENTIONS.122.012768","article-title":"Transcatheter aortic valve replacement in patients with reduced ejection fraction and nonsevere aortic stenosis","volume":"16","author":"Ludwig","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"2026050607120240300_suag016-B14","doi-asserted-by":"crossref","first-page":"101190","DOI":"10.1016\/j.jacadv.2024.101190","article-title":"Early aortic valve replacement in moderate aortic stenosis","volume":"3","author":"Abdelfattah","year":"2024","journal-title":"JACC Adv"},{"key":"2026050607120240300_suag016-B15","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jacc.2024.10.070","article-title":"Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis: TAVR UNLOAD","volume":"85","author":"Van Mieghem","year":"2025","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/advance-article-pdf\/doi\/10.1093\/eurheartjsupp\/suag016\/67300105\/suag016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/28\/Supplement_5\/v1\/67300105\/suag016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/28\/Supplement_5\/v1\/67300105\/suag016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:12:07Z","timestamp":1778065927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/28\/Supplement_5\/v1\/8514191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":15,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2026,3,11]]},"published-print":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suag016","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,3,11]]}}}